ohp | 25301
17-OH-progesterone (LCMS)
Keywords:
17-Hydroxyprogesterone
17-OH Progesterone
17-OH-progesterone
17-OHP
Addison's disease
Adrenal cortex
Amenorrhea
Conn's disease
Cushing's disease
Cycle
Fertility
Hirsutism
Infertility
Sterility
Virilization
Status
Material |
|
||
---|---|---|---|
Hint |
Optimal blood sampling in the morning, 7:30 – 8:00 h; for women between menarche and menopause during the follicular phase. |
||
Min. volume | 500 µL | ||
Stability |
Stability
4 days / 18-25°C
4 days / 2-8°C
1 year / -20°C
|
||
Duration | 2 – 4 days | ||
Frequency | 5 x per week (monday – friday) | ||
Method | Liquid chromatography / mass spectrometry (LCMS) |
Price/Rate
Price |
Price
CHF 61.20
|
---|---|
Rate |
Rate
61.20 TP
|
Reference values
Value and unit | Age and unit | Sex |
---|---|---|
< 12.8 nmol/L | 0 - 3 D | f |
2.36 - 13.83 nmol/L | 0 - 91 D | f |
< 5.2 nmol/L | 4 - 365 D | f |
2.72 - 10.80 nmol/L | 92 - 182 D | f |
4.36 - 17.49 nmol/L | 183 - 300 D | f |
0.1 - 3.5 nmol/L | 1 - 4 Y | f |
< 2.8 nmol/L | 5 - 9 Y | f |
:Puberty stages nmol/L | 5 - 11 Y | f |
:according to Tanner: nmol/L | 5 - 11 Y | f |
P2;P3:<0.5 - 6.7 nmol/L | 5 - 11 Y | f |
P4;P5:<1.1 - 6.1 nmol/L | 5 - 11 Y | f |
< 5.2 nmol/L | 10 - 13 Y | f |
:Puberty stages nmol/L | 12 - 17 Y | f |
:according to Tanner: nmol/L | 12 - 17 Y | f |
P2;P3:<0.5 - 6.7 nmol/L | 12 - 17 Y | f |
P4;P5:<1.1 - 6.1 nmol/L | 12 - 17 Y | f |
Follicular:< 5.7 nmol/L | 12 - 17 Y | f |
luteal phase:< 8.7 nmol/L | 12 - 17 Y | f |
1st trimester:2.36 - 13.83 nmol/L | 12 - 70 Y | f |
2nd trimester:2.72 - 10.80 nmol/L | 12 - 70 Y | f |
3rd trimester:4.36 - 17.49 nmol/L | 12 - 70 Y | f |
0.5 - 8.6 nmol/L | 14 - 17 Y | f |
Follicular:< 5.7 nmol/L | 18 - 39 Y | f |
luteal phase:< 8.7 nmol/L | 18 - 39 Y | f |
. nmol/L | >= 18 Y | f |
Follicular:< 5.7 nmol/L | 40 - 60 Y | f |
luteal phase:< 8.7 nmol/L | 40 - 60 Y | f |
Menopause:< 1.5 nmol/L | 40 - 60 Y | f |
Menopause:< 1.5 nmol/L | >= 61 Y | f |
< 12.8 nmol/L | 3 - 3 D | m |
0.3 - 5.1 nmol/L | 4 - 365 D | m |
0.1 - 3.5 nmol/L | 1 - 4 Y | m |
< 2.8 nmol/L | 5 - 9 Y | m |
:Puberty stages nmol/L | 5 - 17 Y | m |
:according to Tanner: nmol/L | 5 - 17 Y | m |
P2;P3:<0.4 - 3.9 nmol/L | 5 - 17 Y | m |
P4;P5:<1.5 - 5.7 nmol/L | 5 - 17 Y | m |
< 5.2 nmol/L | 10 - 13 Y | m |
0.5 - 8.6 nmol/L | 14 - 17 Y | m |
1.0 - 9.3 nmol/L | 18 - 30 Y | m |
1.3 - 5.9 nmol/L | 31 - 40 Y | m |
1.0 - 5.9 nmol/L | 41 - 50 Y | m |
1.1 - 3.9 nmol/L | 51 - 70 Y | m |
1.0 - 2.0 nmol/L | >= 71 Y | m |